Corporate Liability from Employee Diversion: Costly on Many Fronts
FDA Law Blog
JUNE 22, 2022
This matter is the latest in a recent string of large monetary settlements between the government and health care providers involving employee diversion. The Pharmacist-in-Charge (“PIC”) or DEA-designate is required to certify they have completed the evaluation and document any corrective action.
52 
Let's personalize your content